SAN FRANCISCO–(BUSINESS WIRE)–Uber Technologies, Inc. (NYSE: UBER) today announced the addition of PacSun, Camping World and Lush to its apps, further expanding Uber’s growing retail selection and giving consumers more ways to get the products they need, delivered fast and on-demand. This week, shoppers across the U.S. can order from hundreds of PacSun, Camping World… Continue reading Uber: Uber Expands Retail Selection with PacSun, Camping World and Lush
Category: Official Press Release
GoDaddy Accelerates Airo.ai Momentum with New AI Agents for Small Business Growth
TEMPE, Ariz., Nov. 25, 2025 /PRNewswire/ — GoDaddy (NYSE: GDDY) is packing even more agentic AI power into its recently launched Airo.ai online experience with the addition of six brand-new AI agents. Building on the recent debut of Airo.ai public Beta, these latest tools and capabilities are designed to help simplify marketing, operations, and website management for small businesses – saving… Continue reading GoDaddy Accelerates Airo.ai Momentum with New AI Agents for Small Business Growth
DigiKey Debuts Industry-First Power Supply Configuration Tool
Online tool speeds access to power supply solutions, offering time savings and an accelerated design process THIEF RIVER FALLS, Minn., Nov. 25, 2025 /PRNewswire/ — DigiKey, the leading global electronic components and automation products distributor, has introduced an industry-first power supply configuration tool, which simplifies the process of designing power supply solutions. Continue Reading Engineers, designers and… Continue reading DigiKey Debuts Industry-First Power Supply Configuration Tool
uniball National Signing Day™ Is Here to Stay: 70+ High Schools Nationwide Join 2025-26 Celebration
Back and bigger than ever, the annual tradition cements itself as a signature moment for student-athletes CHICAGO, Nov. 25, 2025 /PRNewswire/ — After a groundbreaking national debut, uniball National Signing Day™ is here to stay. Kicking off this November and continuing through the rest of the school year, more than 70 high schools across the… Continue reading uniball National Signing Day™ Is Here to Stay: 70+ High Schools Nationwide Join 2025-26 Celebration
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
The acquisition of Enci Therapeutics will advance Innova Therapeutics’ lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with cancer including the tumor, and multiple components of the tumor microenvironment including endothelial cells, T-cells,… Continue reading Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
The acquisition of Enci Therapeutics will advance Innova Therapeutics’ lead program, IVT-8086, a humanized monoclonal antibody targeting SFRP2 which is expressed in most solid and hematological cancers. IVT-8086 is the only cancer therapeutic that targets multiple cell types associated with cancer including the tumor, and multiple components of the tumor microenvironment including endothelial cells, T-cells,… Continue reading Innova Therapeutics to Advance Novel Cancer Treatment with Enci Therapeutics Acquisition
Innova Therapeutics fait progresser un nouveau traitement contre le cancer grâce à l’acquisition d’Enci Therapeutics
L’acquisition d’Enci Therapeutics fera progresser le programme phare d’Innova Therapeutics, IVT-8086, un anticorps monoclonal humanisé ciblant SFRP2, qui est exprimé dans la plupart des cancers solides et hématologiques. L’IVT-8086 est la seule thérapie anticancéreuse qui cible plusieurs types de cellules associées au cancer, y compris la tumeur, et plusieurs composants du microenvironnement tumoral, y compris… Continue reading Innova Therapeutics fait progresser un nouveau traitement contre le cancer grâce à l’acquisition d’Enci Therapeutics
Innova Therapeutics bringt mit der Übernahme von Enci Therapeutics eine neuartige Krebsbehandlung voran
Die Übernahme von Enci Therapeutics wird Innova Therapeutics’ führendes Programm IVT-8086 voranbringen, einen humanisierten monoklonalen Antikörper, der auf SFRP2 abzielt, das in den meisten soliden und hämatologischen Krebsarten exprimiert wird. IVT-8086 ist das einzige Krebstherapeutikum, das auf mehrere Zelltypen abzielt, die mit Krebs assoziiert sind, einschließlich des Tumors und mehrerer Komponenten der Tumormikroumgebung, einschließlich Endothelzellen,… Continue reading Innova Therapeutics bringt mit der Übernahme von Enci Therapeutics eine neuartige Krebsbehandlung voran
Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics
La adquisición de Enci Therapeutics impulsará el programa principal de Innova Therapeutics, IVT-8086, un anticuerpo monoclonal humanizado dirigido a SFRP2, que se expresa en la mayoría de los cánceres sólidos y hematológicos. IVT-8086 es el único tratamiento contra el cáncer que se dirige a múltiples tipos de células asociadas con el cáncer, incluyendo el tumor,… Continue reading Innova Therapeutics impulsará un nuevo tratamiento contra el cáncer con la adquisición de Enci Therapeutics
100MW, LLC Announces Strategic Agreement with Block40X, Inc. for $200 Million Bitcoin Infrastructure Development
25 year PSA under $0.03 per kilowatt hour MIAMI, Nov. 25, 2025 /PRNewswire/ — 100MW, LLC (“100MW”) is pleased to announce an agreement with Block40X, Inc. (“Block40X”), establishing a strategic partnership to develop and support one of the world’s most efficient large-scale Bitcoin-mining, AI, and high-performance computing (HPC) campuses. Under the terms of the agreement, Block40X… Continue reading 100MW, LLC Announces Strategic Agreement with Block40X, Inc. for $200 Million Bitcoin Infrastructure Development